<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>E药经理人 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-27T23:14:23+08:00</updated>
  <subtitle>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>Vlog | 今年医药行业最值得期待的大会究竟是什么样？</title>
    <updated>2020-11-27T22:02:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/qP_rXiN2uWRijzaWtiqfew</id>
    <link href="https://mp.weixin.qq.com/s/qP_rXiN2uWRijzaWtiqfew" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【启思会】倒计时1天，请收好这份参会攻略</title>
    <updated>2020-11-27T22:02:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/sBIyc3wq8k0CNxlwQJMHMw</id>
    <link href="https://mp.weixin.qq.com/s/sBIyc3wq8k0CNxlwQJMHMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从梦想到理想，你品一品！施一公携西湖大学科学家分享前沿创新</title>
    <updated>2020-11-27T22:02:58+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/lqNJGChqOF5mp4bNKXd9Fg</id>
    <link href="https://mp.weixin.qq.com/s/lqNJGChqOF5mp4bNKXd9Fg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>独家！医保谈判最新文件曝光！谈判材料递交明日截止，测算专家最看重这几点！</title>
    <updated>2020-11-26T21:36:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/VWFV8R2i8C6BDvOM6rmU2A</id>
    <link href="https://mp.weixin.qq.com/s/VWFV8R2i8C6BDvOM6rmU2A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东、GSK 等疫苗企业将与丁香园共建疫苗服务平台，诊所可免费接入</title>
    <updated>2020-11-26T21:36:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/YhU5uM1tIhmnfNo5_WIwDQ</id>
    <link href="https://mp.weixin.qq.com/s/YhU5uM1tIhmnfNo5_WIwDQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【启思会】倒计时2天，请收好这份参会攻略</title>
    <updated>2020-11-26T21:36:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/S-9mbvw5iXxsBIkkvJgNmA</id>
    <link href="https://mp.weixin.qq.com/s/S-9mbvw5iXxsBIkkvJgNmA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>扬子江入场！拿下8款生物类似药，信达、复宏汉霖、百奥泰迎劲敌</title>
    <updated>2020-11-26T21:36:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-26:/s/D50q3OK4f72C4l7aajlnzg</id>
    <link href="https://mp.weixin.qq.com/s/D50q3OK4f72C4l7aajlnzg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>创新重构产业：一场200人和2000人的对话！</title>
    <updated>2020-11-25T20:37:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/TWFb4Yt-PmdSVzX6PEd8tg</id>
    <link href="https://mp.weixin.qq.com/s/TWFb4Yt-PmdSVzX6PEd8tg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赋能智能制造｜英特尔助力新冠疫苗生产驶入“快车道”</title>
    <updated>2020-11-25T20:37:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/ZS8kXEESN0t86x_frTFadA</id>
    <link href="https://mp.weixin.qq.com/s/ZS8kXEESN0t86x_frTFadA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刘釜均：专注三件事，让天下没有难诊的病</title>
    <updated>2020-11-25T20:37:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/2ONzu3_zjXmfjoHixqOxgQ</id>
    <link href="https://mp.weixin.qq.com/s/2ONzu3_zjXmfjoHixqOxgQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>40个品种集采大厮杀！但最低价不一定中选，山东今日开启带量采购！</title>
    <updated>2020-11-25T20:37:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/eRKWVX1Yl3g2G7_2OH2vOg</id>
    <link href="https://mp.weixin.qq.com/s/eRKWVX1Yl3g2G7_2OH2vOg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一心堂与老百姓会合并吗？一场乌龙引发的联想……</title>
    <updated>2020-11-25T20:37:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/knkmw2x5BScGmBMqKMj6Aw</id>
    <link href="https://mp.weixin.qq.com/s/knkmw2x5BScGmBMqKMj6Aw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>加速上市！八部门联合发文，大湾区可优先使用港澳上市药械</title>
    <updated>2020-11-25T20:37:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/we1M10ALuaBRfyxTORf1JA</id>
    <link href="https://mp.weixin.qq.com/s/we1M10ALuaBRfyxTORf1JA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>史无前例！一年75家药企上市。科创板是否估值过高？创新泡沫2021会破裂吗？6000字长文解读2020年IPO节奏</title>
    <updated>2020-11-24T21:16:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/HsLMjxiOoOkU6blBUlq1_g</id>
    <link href="https://mp.weixin.qq.com/s/HsLMjxiOoOkU6blBUlq1_g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【启思会】倒计时4天，请收好这份参会攻略</title>
    <updated>2020-11-24T21:16:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/MKGfRb4eS68mONeNUCUc0A</id>
    <link href="https://mp.weixin.qq.com/s/MKGfRb4eS68mONeNUCUc0A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>赛诺菲迎来新一代“抗糖”王者，“产品+服务”颠覆慢病治疗</title>
    <updated>2020-11-24T21:16:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/P-4UAXtuXJFDuJ73mAADqw</id>
    <link href="https://mp.weixin.qq.com/s/P-4UAXtuXJFDuJ73mAADqw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二批耗材集采即将来临？国家医保局对人工关节、除颤器等开展数据采集与价格监测</title>
    <updated>2020-11-24T21:16:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/KHwuiKOzcc0GEsmlgcL6hg</id>
    <link href="https://mp.weixin.qq.com/s/KHwuiKOzcc0GEsmlgcL6hg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠病毒之战再传捷报    阿斯利康牛津疫苗发布新进展</title>
    <updated>2020-11-24T21:16:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/-J7NFw7DCZ-H0KV-STJ3Kg</id>
    <link href="https://mp.weixin.qq.com/s/-J7NFw7DCZ-H0KV-STJ3Kg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>投资人视角｜有条件批准政策执行，创新药审评加速与国际接轨</title>
    <updated>2020-11-24T21:16:09+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-24:/s/YVOyk-IdQupvh2TSpPX-FQ</id>
    <link href="https://mp.weixin.qq.com/s/YVOyk-IdQupvh2TSpPX-FQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞、信达、君实、百济PD-1谁的销量高？谁能取胜药价谈判？谁的适应症多？谁进治疗指南多？PD-(L)1价格战已在途！</title>
    <updated>2020-11-23T21:23:04+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/9BuUaUSqSd2zwpnvpUnTPQ</id>
    <link href="https://mp.weixin.qq.com/s/9BuUaUSqSd2zwpnvpUnTPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>